Recommendations on the use of Sulfadoxine-Pyrimethamine (SP)
Recommendations on the use of Sulfadoxine- Pyrimethamine (SP) for Intermittent Preventive Treatment during Pregnancy (IPT) in areas of moderate to high resistance to SP in the African Region
Pregnant women are one of the most vulnerable groups to malaria. In the malaria endemic areas of the African region, each year around 25 million of pregnant women are at risk of Plasmodium falciparum infection during their pregnancy.
(WHO/AFR/MAL/04/01)
